This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Opinion. In the past three years that I’ve worked with the Type 1 community, I’ve proudly watched Type 1 advocacy mature into a potent political force. I’ve witnessed people affected by Type 1 use online organizing and on-the-ground lobbying to change laws and raise awareness, making life better for everyone with diabetes. Along the way, I’ve also seen this community experience growing pains, a phenomenon that happens with all social movements.
This week marked another media milestone for American Well – our company, CEO and several of our partners were featured in a Wall Street Journal (WSJ) cover story on telemedicine and how it is “finally living up to its potential.”. The WSJ story caps a recent shift in the industry – and related news coverage – toward evaluating how major healthcare providers, health plans, employers, and retailers are now using telemedicine, as opposed to the futuristic analyses of days gone by.
Amazing news this week from Apple on their use of Differential Privacy. They didn't invent Differential Privacy , they are not the first to use De-Identification , but they seem to have thought about this. We can't yet tell how well they thought about this, as the details are not clear. That is, they are still not being Transparent. I am not an Apple fanboy, I think they get far too much credit and buzz.
On June 23, President Obama ’s championing for Immigration reform received some sobering news when the Supreme Court thwarted Obama’s plan to protect certain illegal immigrants from possible deportation. It was a blow to those hoping for a change in how America handles undocumented immigrants. However, immigrants are being protected in the way of healthcare, thanks to states like California.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
This June, a 41-year-old man became the first European patient with Type 1 to come off insulin therapy after receiving a transplant of pancreatic islet cells using the BioHub technique. This therapy, engineered by the Diabetes Research Institute (DRI), protects transplanted islet cells from immune system attack. Using the BioHub technique, DRI researchers and collaborators in Italy were able to virtually work together to transplant insulin-producing cells within a biological scaffold on the omen
Unfortunately, researchers are finding that people with one autoimmune condition are prone to others. For example, a recent study has found that people with celiac disease and Type 1 diabetes have a higher risk of also developing autoimmune thyroid disease. The study, published in Diabetes Care , looked at patients in the Swedish National Patient Register.
Unfortunately, researchers are finding that people with one autoimmune condition are prone to others. For example, a recent study has found that people with celiac disease and Type 1 diabetes have a higher risk of also developing autoimmune thyroid disease. The study, published in Diabetes Care , looked at patients in the Swedish National Patient Register.
On Facebook, we asked our readers about whether they are comfortable injecting insulin in public, and whether they noticed a generational divide on this subject. We received a lot of great responses on the subject, many in favor of injecting in public. Here are some of the best*: I’ve never had a problem injecting insulin in public, although I try and be as discreet about it as I can.
The Diabetes Patient Advocacy Coalition (DPAC) and the FDA paired up to host a webinar on the FDA’s efforts to speed up its premarket regulatory approval process for the artificial pancreas. During the webinar, the FDA also signaled its goal to make the technology suitable for insulin therapy for children with diabetes. DPAC president Bennet Dunlap led the webinar, which featured an interview-style discussion with Dr.
At six years old, Chloe Llewellyn (not pictured above) has already had problems with two different schools when it comes to her Type 1 diabetes. Chloe, diagnosed with Type 1 when she was two years old, was turned away in 2014 from a private preschool on the morning she was supposed to return for her second year there. The school’s director told Chloe’s family that he’d meant to get in touch with her earlier to say that the school could no longer accommodate Chloe’s needs, according to Bridget Ll
A British boy with Type 1 diabetes and his family were detained for several hours by security at the Dubai International Airport after they refused a request to put the boy’s insulin pump through an x-ray machine. The boy’s mother, Rachel Humphrey, shared her experience in an open letter to airport officials. According to Humphrey, the family passed through security at London’s Heathrow Airport without incident on a recent trip to Dubai, but ran afoul of Dubai airport security personnel during t
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Two companies across two continents are partnering to bring an artificial pancreas to the market. Cellnovo, a French company known for it’s connected insulin patch pump, has partnered with TypeZero Technologies to create an artificial pancreas system for people with Type 1 diabetes. The system will rely on Dexcom’s continuous glucose meter to monitor glucose levels, TypeZero’s inControl artificial pancreas software to calculate management of blood sugar levels and insulin delivery, and Cellnovo’
A child’s socioeconomic status may be able to predict his or her health outcomes on insulin pump therapy, even in a country with universal health care coverage. A new University of Toronto study seems to demonstrate that Canadian children with Type 1 who are pump users and come from households of lower socioeconomic status might be at an increased risk of diabetic ketoacidosis or other complications than their more well-off peers.
Metropolitan Boston is home to institutions housing world-class diabetes care clinics and research facilities, yet Massachusetts is one holdout where school glucose testing, administration of insulin, and even emergency glucagon injections must be performed by or directly supervised by a school nurse. State public health regulation prohibits school nurses from delegating administration of any “parenteral” medication to a child – a parenteral medication is any medication that can’t be taken
Seen buzz on Facebook about a restaurant that was unfriendly to people taking insulin? We are here to once again explain an important diabetes news story….with memes. 1. The owner of Mike’s Pig Pen decided people taking insulin were icky to look at, so he hung up a sign in his restaurant about it. 2. A Facebook user publically posted a photo of the sign, with some commentary. 3.
Healthcare communication has evolved from handwritten notes and paper charts to digital tools like EHRs, telemedicine, and AI-powered platforms. This blog explores how these advancements improve patient outcomes, streamline care delivery, and enhance provider collaboration. Learn about the role of mobile health (mHealth) apps, secure messaging, and social media in bridging communication gaps.
This week marked another media milestone for American Well – our company, CEO and several of our partners were featured in a Wall Street Journal (WSJ) cover story on telemedicine and how it is “finally living up to its potential.”. The WSJ story caps a recent shift in the industry – and related news coverage – toward evaluating how major healthcare providers, health plans, employers, and retailers are now using telemedicine, as opposed to the futuristic analyses of days gone by.
Jennifer McGuire is a director of health system solutions for American Well. The U.S. News and World Report recently released its national ranking of the Best Children’s Hospitals. Always a go-to resource for learning about the most innovative and effective hospitals, the report gathers clinical data and compiles surveys from more than 10,000 pediatric specialists on where they would send the sickest children in their specialties.
Jennifer McGuire is a director of health system solutions for American Well. The U.S. News and World Report recently released its national ranking of the Best Children’s Hospitals. Always a go-to resource for learning about the most innovative and effective hospitals, the report gathers clinical data and compiles surveys from more than 10,000 pediatric specialists on where they would send the sickest children in their specialties.
This week we announced the appointment of longtime Amwell technology executive Jon Freshman to Chief Technology Officer. Following the news, VentureFizz, a popular Boston-area technology outlet, reached out with a few questions for Jon on what his appointment means for the company and what it’s like working on the engineering team. Below is a preview of the Q&A which you can read in full on VentureFizz here.
Speaker: Duke Heninger, Partner and Fractional CFO at Ampleo & Creator of CFO System
Are you ready to elevate your accounting processes for 2025? 🚀 Join us for an exclusive webinar led by Duke Heninger, a seasoned fractional CFO and CPA passionate about transforming back-office operations for finance teams. This session will cover critical best practices and process improvements tailored specifically for accounting professionals.
This week we announced the appointment of longtime American Well technology executive Jon Freshman to Chief Technology Officer. Following the news, VentureFizz, a popular Boston-area technology outlet, reached out with a few questions for Jon on what his appointment means for the company and what it’s like working on the engineering team. Below is a preview of the Q&A which you can read in full on VentureFizz here.
Telemedicine Today: June 2016. Welcome to the June 2016 edition of Avizia’s Telemedicine Today! Each month we re-visit some of the most exciting news and influential events from the month. From success stories, to legislative updates, research findings and product updates, we’ll share the latest hypes, trends and news you can’t miss. Closing the Telehealth Gap.
This week we announced the appointment of longtime American Well technology executive Jon Freshman to Chief Technology Officer. Following the news, VentureFizz, a popular Boston-area technology outlet, reached out with a few questions for Jon on what his appointment means for the company and what it’s like working on the engineering team. Below is a preview of the Q&A which you can read in full on VentureFizz here.
An earlier version of this article appeared on MedCity. A recent study by Willis Towers Watson found that telehealth could save as much as $6 billion annually in U.S. healthcare costs. While this figure indicates huge potential within healthcare systems for reducing medical costs with telehealth, it’s equally important to break down these numbers into more specific return on investment use cases and data.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
An earlier version of this article appeared on MedCity. A recent study by Willis Towers Watson found that telehealth could save as much as $6 billion annually in U.S. healthcare costs. While this figure indicates huge potential within healthcare systems for reducing medical costs with telehealth, it’s equally important to break down these numbers into more specific return on investment use cases and data.
As Medtronic prepares to seek FDA approval for an artificial pancreas, many have wondered why it’s taken so long to get to this point. A recent study suggests that might be because the FDA may be slower to approve medical devices than drugs, according to a report by Mass Device. According to the Harvard Business School study, the approval process of “breakthrough” medical devices is a much more expensive and time-consuming process than that of blockbuster prescription drugs.
Everyone loves a heartwarming story of a dog, and the Type 1 diabetes community especially loves heartwarming stories of dogs which can detect hypoglycemia. But recently a group of researchers have dared to ask whether dogs are the best tool for detecting lows. In recent years, there has been ample anecdotal evidence that well-trained diabetes alert dogs can detect lows, but little study has been done to compare whether trained dogs can outperform other diabetes self-care tools, like continuous
An Australian woman who wrestles with diabulimia has gone public to share the physical toll the disorder has taken on her body. In a Daily Mail Australia report, Skye Simpson shared how skipping insulin injections has left her with blurred vision, bald patches, and no teeth. Simpson first began to skip insulin after she was complimented for her looks following an illness.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
A new study suggests that children with Type 1 diabetes might be more at risk of epilepsy. For the study , researchers collected records from the Taiwan National Health Insurance Research Database, which included 2,600 adolescents with Type 1. They looked to see how often a child with Type 1 also had epilepsy, and then compared that rate to the rate of epilepsy in a control group of 26,000 teens who did not have Type 1.
Be careful what health info you share on Android-based apps, according to a Fierce HealthCare report. In a new study, researchers found that Android-based diabetes apps sometimes collect private health data and share it with outside third parties without warning users. Researchers with the Illinois Institute of Technology Chicago-Kent College of Law found that 81 percent of the 211 Android-based diabetes apps reviewed did not have privacy policies.
In recent years, Vitamin D levels have become a yardstick for researchers to measure everything from heart health to bone density. Now, researchers have found that teens with Type 1 diabetes could be at increased risk of a Vitamin D deficiency. For the study , researchers at the University of Pennsylvania School of Nursing examined blood samples of 200 adolescents treated for diabetes at the Diabetes Center for Children in Philadelphia.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
80 
Let's personalize your content